Company / Tangible Book Value per Share
Actinium Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.25
FY2025
5-year range
$0.25 / $4.19
FY2021-FY2025
Trend
-80.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has declined for 4 consecutive years, from $4.19 in FY2021 to $0.25 in FY2025.
Based on SEC 10-K filings.
0.25 in FY2025 with a 3-year CAGR of -57.7%.
Declined from $2.59 to $0.25 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -57.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Actinium Pharmaceuticals, Inc.'s tangible book value per share has declined for 4 consecutive years.
- In FY2025, tangible book value per share decreased 80.9% year-over-year.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2011.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.25 | -80.9% |
| FY2024 | $1.32 | -49.2% |
| FY2023 | $2.59 | -22.0% |
| FY2022 | $3.32 | -20.8% |
| FY2021 | $4.19 | +4616.9% |
| FY2011 | $0.09 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026